22 May 2013
Keywords: autoimmune, colloral, shows, efficacy, rheumatoid, arthritis, usa
Article | 17 July 1995
AutoImmune of the USA has announced positive results from its Phase II
trial of Colloral (A1200), a candidate treatment for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 July 1995
21 May 2013
© 2013 thepharmaletter.com